InnoMed Technologies introduces two new CPAP devices

Monday, December 08, 2003

BOCA RATON, Fla.--(BUSINESS WIRE)--InnoMed Technologies introduced two new CPAP devices today at the American Association for Respiratory Care Conference, being held in Las Vegas today and tomorrow. InnoMed's critical care division unveiled to the public its Nasal-Aire Critical Care device for use in hospital and critical care environments. Based on the highly successful Nasal-Aire CPAP interface, the new device is a disposable unit which is expected to garner a large portion of the critical care CPAP and non-invasive ventilation market its first year out.

Additionally, the 'Nasal-Pap,' a compact and comfortable interface developed to complement InnoMed's line of 'state of the art' CPAP therapy devices, was also unveiled.

'These two new devices demonstrate that InnoMed's engineering and design capabilities are at the forefront of the sleep and critical care respiratory industries,' said InnoMed C.E.O., Patrick Karem. 'We are pleased that these new designs will not only make InnoMed's customers lives happier and healthier, but will also spur innovation in the industry as a whole.'

InnoMed designs, manufactures and markets the innovative Nasal-Aire and Nasal-Aire II Nasal CPAP interface system as well as the InnoMed-Aire line of CPAPs. Independent clinical trials have shown that when patients are given a choice between using the Nasal-Aire or the three leading competitive masks, manufactured by Resmed, Inc. (NYSE:RMD), Respironics (Nasdaq:RESP), and Mallinckrodt, 98% of the time Nasal-Aire was chosen.

InnoMed Technologies, Inc., is a research-oriented, privately held, 21st Century medical technologies company. The company is poised to bring new and more effective medical products and devices to the public through a medical development and engineering team, as well as acquisitions of other medical related companies. InnoMed holds several patents and has several patents pending. More information regarding InnoMed Technologies is available at http://www.innomedinc.com

A Private Securities Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain information included in this press release (as well as information included in written statements to be made) contain statements that are forward-looking, such as those relating to consummation of the transaction, anticipated future revenue of the Company, and success of current public offerings. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward looking statements.



About Innomed Technologies, Inc.


Innomed Technologies, Inc., is the leading manufacturer of nasal cannula interface devices for the treatment of obstructive sleep apnea. The company is headquartered in Boca Raton, Florida and has close relationships with sleep centers throughout the world.

A Private Securities Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release (as well as information included in written statements to be made) contain statements that are forward-looking, such as those relating to consummation of the transaction, anticipated future revenue of the Company's, and success of current public offerings. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward looking statements.